Biogen (BIIB) Current Taxes (2009 - 2026)

Biogen (BIIB) has reported Current Taxes for 18 consecutive years, with $93.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Taxes fell 85.05% year-over-year to $93.6 million; the TTM figure through Mar 2026 stood at $93.6 million (down 85.05% YoY), while the FY2025 annual figure was $114.8 million, down 79.06% from the prior year.
• Current Taxes came in at $93.6 million for Q1 2026 at Biogen, down from $114.8 million in the prior quarter.
• The five-year high for Current Taxes was $626.1 million in Q1 2025, with the low at $93.6 million in Q1 2026.
• Average Current Taxes over 5 years is $277.0 million, with a median of $257.4 million recorded in 2023.
• Across the five-year window, Current Taxes soared 170.8% in 2025 and plunged 85.05% in 2026, its largest moves.
• Year by year, Current Taxes stood at $259.9 million in 2022, then retreated by 0.96% to $257.4 million in 2023, then jumped by 113.01% to $548.3 million in 2024, then tumbled by 79.06% to $114.8 million in 2025, then decreased by 18.47% to $93.6 million in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $93.6 million, $114.8 million, and $103.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.